Sign in →

Test Code VDSF VDRL, Spinal Fluid

Reporting Name

VDRL, CSF

Useful For

Aiding in the diagnosis of neurosyphilis

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Specimen Type

CSF


Specimen Required


Collection Container/Tube: Sterile vial

Submission Container/Tube: Plastic vial

Specimen Volume: 0.5 mL

Collection Instructions: Submit specimen collected in vial 2, if possible. If not, note which vial from which the aliquot was obtained.


Specimen Minimum Volume

0.2 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
CSF Frozen (preferred) 14 days
  Refrigerated  14 days

Day(s) Performed

Monday through Friday

Test Classification

This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.

CPT Code Information

86592

LOINC Code Information

Test ID Test Order Name Order LOINC Value
VDSF VDRL, CSF 5290-2

 

Result ID Test Result Name Result LOINC Value
9028 VDRL, CSF 5290-2

Clinical Information

VDRL is a nontreponemal serologic test for syphilis that uses a cardiolipin-cholesterol-lecithin antigen to detect reaginic antibodies. The VDRL test performed on cerebrospinal fluid can be used to diagnose neurosyphilis in patients with a prior history of syphilis infection.

 

The presence of neurosyphilis in untreated patients can be detected by the presence of pleocytosis, elevated protein, and a positive VDRL.

Cautions

VDRL testing on spinal fluid gives a high percentage of false-negative results.

Report Available

1 to 4 days

Specimen Retention Time

14 days

Reject Due To

Gross hemolysis Reject
Gross lipemia Reject

Method Name

Flocculation/Agglutination

Reflex Tests

Test ID Reporting Name Available Separately Always Performed
VDSFQ VDRL Titer, CSF No No

Testing Algorithm

If this test is positive, a VDRL titer will be performed at an additional charge.

 

For more information, see Meningitis/Encephalitis Panel Algorithm.